Insights

Vitrolife AB

Nasdaq Stockholm · LEI 5493001WDZMONMSPPR49· Fiscal year 2025

Staff cost per employee
Not disclosed
Employees
Not disclosed

Quick read

  • Revenue fell 4.7% year over year.
  • Operating loss of $474.8M in 2025.

Last 3 years

Revenue
$354.4M2024$337.8M2025
Operating income
$76.9M2024-$474.8M2025

See the share price on Google Finance ↗

Investor metrics

2025
Operating margin
-140.6%
Net margin
-145.7%
ROE
-63.5%
Debt-to-equity
40.9%
Equity ratio
71.0%

USD at SEK 10.18 per $1 (2026-11-20, ExchangeRate-API)

Staff costs from the annual report (wages, social charges, pensions) divided by the average number of employees. Usually higher than take-home pay.

audited consolidated financial statements · View the annual report (filings.xbrl.org)

Not investment advice. Figures come from public filings and may contain errors.